Related Experiment Videos

Effect of renal mass reduction on kidney tissue concentration of gentamycin following a single dose

M V Pahl1, N D Vaziri, P S Leitman

  • 1University of California, Irvine MedicalCenter, Orange.

Research Communications in Chemical Pathology and Pharmacology
|June 1, 1988
PubMed

Insights

Reduced kidney mass increases gentamycin concentration in renal tissue, potentially exacerbating aminoglycoside nephrotoxicity in patients with pre-existing renal disease.

Area of Science:

  • Nephrology
  • Pharmacology
  • Toxicology

Background:

  • Pre-existing renal disease complicates aminoglycoside therapy due to concerns about nephrotoxicity.
  • Aminoglycoside nephrotoxicity is linked to drug concentration within renal tissue.

Purpose of the Study:

  • To investigate the impact of reduced renal mass on gentamycin concentration in renal tissue.
  • To determine if diminished renal function alters drug accumulation in the kidneys.

Main Methods:

  • Male Sprague-Dawley rats underwent progressive renal mass reduction (nephrectomy).
  • Animals received a single dose of gentamycin.
  • Serum, urinary, and renal tissue gentamycin concentrations were measured.

Main Results:

  • Serum gentamycin levels were elevated in nephrectomized rats.
  • Renal tissue gentamycin concentrations were significantly higher in rats with reduced renal mass compared to controls.
  • Urinary gentamycin excretion rate correlated positively with residual renal tissue weight.

Conclusions:

  • Reduced renal mass leads to higher renal tissue gentamycin concentrations after a single dose.
  • This finding suggests an increased risk of aminoglycoside nephrotoxicity in individuals with compromised kidney function.

Related Concept Videos